Unique ID issued by UMIN | UMIN000040890 |
---|---|
Receipt number | R000046686 |
Scientific Title | Effectiveness and safety evaluation of online dementia medical care |
Date of disclosure of the study information | 2020/06/25 |
Last modified on | 2023/12/28 09:55:17 |
Effectiveness and safety evaluation of dementia medical care using online medical care
Effectiveness and safety evaluation of dementia medical care using online medical care
Effectiveness and safety evaluation of online dementia medical care
Effectiveness and safety evaluation of online dementia medical care
Japan |
dementia
Neurology | Psychiatry |
Others
NO
Evaluating the effectiveness and safety of online medical care for patients with dementia
Safety
Confirmatory
Pragmatic
Phase I,II
The main endpoints in this study are measured at the start of the study (0 weeks), 24 weeks, and 48 weeks by the three-time evaluation Zarit care burden scale.
Cognitive function(MMSE), clinical dementia rating(CDR), questionnaire version Neuropsychiatric Inventory-Brief Questionnaire Form (NPI-Q), Geriatric depression scale 15 (GDS15) at the start of the study (0weeks), 24 weeks, 48weeks 3evaluations.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
2
Treatment
Maneuver |
Face-to-face consultation period
online medical treatment combination period
50 | years-old | <= |
95 | years-old | > |
Male and Female
Patients who visit our memory clinic.
Patients with dementia or mild cognitive impairment between the ages of 50 and under 95.
Person who can determine that necessary inspection can be performed on the specified date after obtaining consent
Study partners have at least 7 hours of contact with the subject per week and can accompany all consultations during the observation period.
Person who obtained consent in writing from the research participant and study partner
Person who can use online medical care.
Person with a history of substance use disorder other than smoking or being treated
Person who has a history of epilepsy or is being treated
Persons receiving antidepressants, antipsychotics, hypnotics including long-term sleeping pills
Persons with a history of psychiatric/neurological disorders that affect cognitive function
Persons with serious complications
24
1st name | Daisuke |
Middle name | |
Last name | Ito |
Keio University School of Medicine
Department of Neurology
1608582
Tokyo
0353633788
dito@keio.jp
1st name | Daisuke |
Middle name | |
Last name | Ito |
Keio University School of Medicine
Department of Neurology
1608582
35 Shinanomachi, Shinjuku-ku,Tokyo 160-8582, Japan
0353633788
dito@keio.jp
Keio University School of Medicine
Keio University School of Medicine
Other
Japan
Keio University School of Medicine Ethics Committee
35 Shinanomachi, Shinjuku-ku,Tokyo 160-8582, Japan
0333531211
keio@esct.bvits.com
NO
2020 | Year | 06 | Month | 25 | Day |
Unpublished
13
No longer recruiting
2020 | Year | 06 | Month | 25 | Day |
2020 | Year | 06 | Month | 22 | Day |
2020 | Year | 06 | Month | 30 | Day |
2023 | Year | 03 | Month | 31 | Day |
2020 | Year | 06 | Month | 25 | Day |
2023 | Year | 12 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046686
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |